InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Chan Phillip P., Chief Executive Officer. Officer active across 1 companies, notably Cytosorbents Corp. In total, 6 reports have been recorded. Total volume traded: €84k. The latest transaction was filed on 16 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations6 total
€3,8962,221 shares@ €1.75410.0097% mcap4.6% of flow
Common Stock
SEC:0001104659-22-072979:0·
Ideal exit: 13 Mar 2023 (T+270)
€32,75616,000 shares@ €2.04720.082% mcap39.1% of flow
Common Stock
SEC:0001104659-22-070156:0·
Ideal exit: 6 Mar 2023 (T+270)
€357100 shares@ €3.57061.5% of flow
Common Stock
SEC:0001104659-22-000566·
Ideal exit: 25 Sept 2022 (T+270)
€357100 shares@ €3.57060.0009% mcap0.4% of flow
Common Stock
SEC:0001104659-22-000566:0·
Ideal exit: 25 Sept 2022 (T+270)
€23,2445,000 shares@ €4.648898.5% of flow
Common Stock
SEC:0001104659-21-148900·
Ideal exit: 6 Sept 2022 (T+270)
€23,2445,000 shares@ €4.64880.058% mcap27.7% of flow
Common Stock
SEC:0001104659-21-148900:0·
Ideal exit: 6 Sept 2022 (T+270)
6 of 6 declarations
About Chan Phillip P.
Phillip P. Chan is the Chief Executive Officer of Cytosorbents Corp. He is responsible for the overall leadership of the company, which specializes in developing innovative medical technologies. Chan's mission is to guide the company to new heights in research and development while ensuring regulatory compliance and operational efficiency. His leadership is essential for the continued growth and expansion of Cytosorbents.
